IL142069A0 - Methods of downmodulating the immune response to therapeutic proteins - Google Patents

Methods of downmodulating the immune response to therapeutic proteins

Info

Publication number
IL142069A0
IL142069A0 IL14206999A IL14206999A IL142069A0 IL 142069 A0 IL142069 A0 IL 142069A0 IL 14206999 A IL14206999 A IL 14206999A IL 14206999 A IL14206999 A IL 14206999A IL 142069 A0 IL142069 A0 IL 142069A0
Authority
IL
Israel
Prior art keywords
downmodulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
IL14206999A
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of IL142069A0 publication Critical patent/IL142069A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
IL14206999A 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins IL142069A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Publications (1)

Publication Number Publication Date
IL142069A0 true IL142069A0 (en) 2002-03-10

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14206999A IL142069A0 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Country Status (21)

Country Link
EP (1) EP1115423A1 (en)
JP (1) JP2002526455A (en)
KR (1) KR20010085830A (en)
CN (1) CN1331602A (en)
AU (1) AU761206B2 (en)
BR (1) BR9913991A (en)
CA (1) CA2343916A1 (en)
CZ (1) CZ20011021A3 (en)
EA (1) EA005236B1 (en)
HK (1) HK1039059A1 (en)
HU (1) HUP0103960A3 (en)
IL (1) IL142069A0 (en)
LT (1) LT4920B (en)
LV (1) LV12768B (en)
MX (1) MXPA01002898A (en)
NO (1) NO20011412L (en)
NZ (1) NZ511034A (en)
PL (1) PL346796A1 (en)
SI (1) SI20626A (en)
WO (1) WO2000016801A1 (en)
ZA (1) ZA200103156B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
AU6173501A (en) * 2000-05-19 2001-12-03 Blood Res Center Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
EP1636579A4 (en) * 2003-06-10 2011-10-05 Smiths Detection Inc Sensor arrangement
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
US4868112A (en) 1985-04-12 1989-09-19 Genetics Institute, Inc. Novel procoagulant proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (en) 1990-02-05 1994-09-02 Tm Innovation PROCESS FOR THE PREPARATION OF HUMAN FACTOR VIII AND FACTOR VIII ANALOGS.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
DE122007000078I2 (en) 1991-06-27 2011-01-13 Bristol Myers Squibb Co CTL4A receptor, fusion proteins containing it and their use
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
EP0776217A1 (en) * 1994-08-19 1997-06-04 Novo Nordisk A/S A method of treating a patient with a biologically active compound
JPH10507758A (en) * 1994-10-19 1998-07-28 ジェネティック セラピー，インコーポレイテッド Gene therapy with simultaneous administration of adenovirus and immunosuppressive drugs
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
PT892643E (en) * 1996-03-20 2002-09-30 Univ Emory METHODS FOR INHIBITING AN IMMUNITY RESPONSE BLOCKING THE GP39 / CD40 AND CTLA4 / CD28 / B7 CIRCUITS AND USES FOR THE EFFECT
JP2001508450A (en) * 1997-01-10 2001-06-26 バイオジェン インコーポレイテッド Methods of therapeutic administration of anti-CD40L compounds
EE9900587A (en) * 1997-06-20 2000-08-15 Biogen, Incorporated CD154 blockade in therapeutic protein inhibitor syndrome
US8082673B2 (en) 2009-11-06 2011-12-27 Hexagon Metrology Ab Systems and methods for control and calibration of a CMM

Also Published As

Publication number Publication date
EA200100385A1 (en) 2001-10-22
BR9913991A (en) 2001-07-03
CA2343916A1 (en) 2000-03-30
JP2002526455A (en) 2002-08-20
MXPA01002898A (en) 2002-06-04
LV12768A (en) 2001-12-20
NO20011412L (en) 2001-05-16
NO20011412D0 (en) 2001-03-20
CZ20011021A3 (en) 2001-10-17
SI20626A (en) 2002-02-28
ZA200103156B (en) 2002-07-18
HUP0103960A3 (en) 2003-09-29
PL346796A1 (en) 2002-02-25
LT2001045A (en) 2002-01-25
AU6057899A (en) 2000-04-10
LT4920B (en) 2002-06-25
EA005236B1 (en) 2004-12-30
CN1331602A (en) 2002-01-16
WO2000016801A1 (en) 2000-03-30
KR20010085830A (en) 2001-09-07
HUP0103960A2 (en) 2002-02-28
HK1039059A1 (en) 2002-04-12
LV12768B (en) 2002-06-20
EP1115423A1 (en) 2001-07-18
WO2000016801A9 (en) 2000-10-26
AU761206B2 (en) 2003-05-29
NZ511034A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
ID25792A (en) ANTIBODIES OF HUMAN CD40
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
IL135673A0 (en) Therapeutic uses of quinoline derivatives
EP1033994A4 (en) Methods of preparation of bioginkgo
ID28441A (en) THERAPY TO IMPROVE CONSCIOUSNESS
FI964193A (en) Preparation of purines
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
PL346796A1 (en) Methods of downmodulating the immune response to therapeutic proteins
FI953580A (en) Preparation of acyclovir
GB9822619D0 (en) Immune response stimulation
DE29820137U1 (en) Multifunctional children's furniture
DE9400033U1 (en) Massage ball
GB9727410D0 (en) Improvements relating to adjustable furniture
GB9727230D0 (en) Improvements relating to adjustable furniture
KR960025637U (en) Easy to adjust connector
KR960019736U (en) Structure of the sole
NO965332D0 (en) Therapeutic preparation
GB9820388D0 (en) Improvements relating to furniture
TW315720U (en) Structure of treadmill also having the resupination function of human body
KR960013110U (en) Chiropractor easy to attach to the bottom of the shoe
TW322782U (en) Structure improvement of walker
TW351186U (en) Improvement of exercise walker
HU9501133D0 (en) Device to make easier the claimbing of the stairs